Seeking men and women who are or have been smokers and are at greater risk for lung cancer for a study to improve lung cancer screening
11 Studies found
Study Of An Investigational Combination Of Drugs For Advanced Non-Squamous Non-Small Cell Lung Cancer
Seeking men and women whose non-squamous non-small cell lung cancer tumor has a STK11 gene mutation for a study of an investigational drug combination.
Study Of A Targeted Investigational Drug For Non-Small Cell Lung Cancer That Has Come Back Or Spread After Treatment
Seeking men and women whose non-small cell lung cancer has come back or spread after treatment for a study of an investigational drug that is targeted for tumors with a specific biologic marker.
Seeking Men and Women 18 years or older who have small cell lung cancer, which can spread to the brain.
Seeking Men and Women over 18 years old who have early stage non-small cell lung cancer that was surgically removed and may have been treated with chemotherapy and/or radiation. The tumor removed has a mutation of a gene called EGFR (Epidermal Growth Factor Receptor).
Seeking adult men & women whose tumor cells have a change in a gene called ALK that causes the cells to grow and spread.
Seeking adults with non-small cell lung cancer for a study comparing immunotherapy to targeted therapy based on tumor characteristics
People with non-small cell lung cancer that has spread outside their lungs and whose tumor has a particular biomarker are sought for a study of an investigational drug.
Study Of Immunotherapy Alone Or In Combination With Chemotherapy For Advanced Nonsquamous Non-Small Cell Lung Cancer
Non-squamous non-small cell lung cancer patients whose cancer has been tested to be PD-L1 positive (a kind of tumor marker) sought for study comparing two usual approaches to treatment.
Seeking volunteers who received immunotherapy, but whose non-small cell lung cancer has spread outside their lungs and either their tumor sample biomarker does not match one of the open treatment studies or they were not a candidate for a biomarker-matched study for a study of an investigational drug combination.
Addition Of An Investigational Drug To The Usual Treatment For Limited Stage Small Cell Lung Cancer (Ls-Sclc)
Men and women with limited-stage small cell lung cancer, which has not spread outside of their chest area sought for a study comparing how cancer responds when adding an investigational drug to the usual treatment for small cell lung cancer